283 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis C"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
2 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
3 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C;   Cirrhosis;   Hepatitis C Virus
Interventions: Drug: Ombitasvir;   Drug: Paritaprevir;   Drug: Ritonavir;   Drug: Dasabuvir;   Drug: Ribavirin
4 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
5 Recruiting A Two Part, Open-label Study to Evaluate the Safety and Effectiveness of ABT-450/r/ABT-267 or ABT-450/r/ABT-267 and ABT-333 Given With or Without a Drug Called Ribavirin in People With Both Hepatitis C Virus Genotype 1 or 4 Infection and Human Immunodeficiency Virus, Type 1 Infection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Recruiting A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)
Condition: Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: Ribavirin
7 Recruiting Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: Hepatitis C Virus
Interventions: Drug: Simeprevir 150 mg;   Drug: Daclatasvir 60 mg;   Drug: Sofosbuvir 400 mg
8 Unknown  Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection;   Hepatitis C
Intervention: Behavioral: Contigent voucher incentive (CVI)
9 Unknown  Pioglitazone in Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Pioglitazone
10 Unknown  Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-Interferon alpha2a plus Ribavirin
11 Recruiting A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Ombitasvir/Paritaprevir/Ritonavir;   Drug: Dasabuvir;   Drug: Ribavirin
12 Unknown  Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention:
13 Unknown  Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
Conditions: Hepatitis C;   Hepatitis B
Intervention: Drug: Pegasys; Copegus.
14 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: ribavirin (RBV)
15 Unknown  Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?
Condition: Hepatitis C
Interventions: Drug: Peg+ Vitamin D+ Ribavirine;   Drug: Peg+  Ribavirine
16 Unknown  Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention:
17 Unknown  Directly Observed Hepatitis C Treatment in Methadone Clinics
Conditions: Hepatitis C;   Medication Adherence
Interventions: Other: enhanced DOT (both pegylated interferon alfa-2a and ribavirin);   Other: standard DOT (PEG-DOT control arm)
18 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
19 Available Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C
Interventions: Drug: Telaprevir + peginterferon alfa + ribavirin;   Drug: peginterferon alfa + ribavirin
20 Recruiting Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: TT-034

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years